newsfilter
← Latest News
PR Newswire·

Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.

TORONTO, Oct. 18, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to